Welcome, and thank you for accessing our Media Room, which is your gateway to relevant information about the HIV Vaccine Trials Network (HVTN). We are a team of people on a scientific journey to find an effective preventive HIV vaccine. Our work is made possible through the commitment of our heroes – individuals, families, and communities around the world who contribute to the success and impact of our work.
Latest News Release
Neither frequency of alcohol use, binge drinking, marijuana, nor other drug use negatively impacts retention and adherence rates in phase I clinical trials of preventive HIV vaccines. These were the findings revealed in a meta-analysis performed by an HIV Vaccine Trials Network (HVTN) Research and Mentorship Program (RAMP) scholar to assess the patterns of substance use among enrolled participants, and the impact substance use has on retention in phase 1 preventive HIV vaccine clinical trials. Read more >